Can lung cancer be cured with Brigatinib/Brigatinib?

Brigatinib/Brigatinib (Brigatinib) is a drug used to treat non-small cell lung cancer (< span>NSCLC) drugs, especially suitable for ALK fusion-positive NSCLC patients. However, when it comes to the treatment of lung cancer, regardless of the treatment method used, recovery depends on many factors, including the stage of the disease, the characteristics of the tumor, and the condition of the individual patient.

AlthoughBrigatinib/Brigatinib has shown significant clinical efficacy in the treatment of ALKpositive NSCLC patients, but there is no guarantee that all patients will be cured. Brigatinib/Brigatinibmainly inhibits the growth and spread of tumors, can prolong the progression-free survival and overall survival of patients, and reduce the risk of tumor progression. However, for patients with advanced lung cancer or distant metastasis, complete recovery may be relatively difficult.

The treatment of lung cancer is a comprehensive strategy, which usually uses a variety of treatments, such as surgical resection, radiotherapy, chemotherapy, targeted therapy and immunotherapy. Brigatinib/Brigatinib is usually used for targeted therapy, which can effectively control the growth and metastasis of tumors. However, using Brigatinib/Brigatinib alone often cannot achieve the goal of complete recovery.

For patients with early-stage lung cancer, surgical resection is a common treatment method, which provides the best treatment effect and patient survival chance by completely removing the tumor tissue. For patients with advanced lung cancer, multiple treatments are usually required to achieve the best therapeutic effect.

Brigatinib/Brigatinib has been launched in China and has been included in medical insurance. Since it has just been approved for marketing, patients may not be able to buy it in domestic pharmacies. If you need to purchase it in China, please consult the local pharmacy. However, the price is quite high, more than 10,000 yuan. ForeignBrigatinib/Brigatinib is mainly a generic drug, mainly from Bangladesh and Laos. The price of the international version of the Bangladeshi generic drug Yaopin is about 2000 yuan The price is about 90mg*30 tablets; the price of the Laos version of the generic drug is about 600 and the specifications are smaller. And the ingredients of domestic original drugs and foreign generic drugs are basically the same.